See more : Hypertension Diagnostics, Inc. (HDII) Income Statement Analysis – Financial Results
Complete financial analysis of Yifeng Pharmacy Chain Co., Ltd. (603939.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yifeng Pharmacy Chain Co., Ltd., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Royal Bank of Canada (0QKU.L) Income Statement Analysis – Financial Results
- Safari Industries (India) Limited (SAFARI.NS) Income Statement Analysis – Financial Results
- Tsukiji Uoichiba Company, Limited (8039.T) Income Statement Analysis – Financial Results
- Chayo Group Public Company Limited (CHAYO.BK) Income Statement Analysis – Financial Results
- Cosmo Lady (China) Holdings Company Limited (2298.HK) Income Statement Analysis – Financial Results
Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
About Yifeng Pharmacy Chain Co., Ltd.
Yifeng Pharmacy Chain Co., Ltd. retails pharmaceutical products in China. As of March 31, 2021, it operates approximately 6,279 pharmaceutical chain stores in Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The company was founded in 2001 and is based in Changsha, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 22.59B | 19.89B | 15.33B | 13.14B | 10.28B | 6.91B | 4.81B | 3.73B | 2.85B | 2.23B | 1.80B | 1.54B | 1.22B |
| Cost of Revenue | 14.03B | 12.03B | 9.14B | 8.15B | 6.27B | 4.17B | 2.88B | 2.25B | 1.73B | 1.34B | 1.11B | 966.14M | 784.10M |
| Gross Profit | 8.56B | 7.86B | 6.18B | 4.99B | 4.01B | 2.75B | 1.92B | 1.48B | 1.12B | 887.00M | 697.47M | 573.33M | 440.00M |
| Gross Profit Ratio | 37.89% | 39.53% | 40.35% | 37.98% | 39.01% | 39.73% | 40.04% | 39.62% | 39.23% | 39.77% | 38.66% | 37.24% | 35.94% |
| Research & Development | 33.55M | 25.31M | 15.64M | 8.31M | 5.37M | 3.24M | 0.00 | 14.79M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 148.59M | 132.73M | 83.01M | 92.17M | 63.25M | 28.02M | 14.54M | 9.75M | 8.62M | 8.00M | 5.54M | 5.38M | 53.32M |
| Selling & Marketing | 5.49B | 4.88B | 4.06B | 3.23B | 2.68B | 1.90B | 1.29B | 1.02B | 758.46M | 577.23M | 468.06M | 403.61M | 304.32M |
| SG&A | 6.45B | 5.01B | 4.14B | 3.32B | 2.74B | 1.92B | 1.31B | 1.03B | 767.08M | 585.23M | 473.60M | 408.99M | 357.64M |
| Other Expenses | 15.25M | 797.73M | 567.47M | 450.33M | 394.67M | 2.94M | 908.73K | 9.70M | 7.17M | 6.71M | 2.15M | 1.95M | 3.28M |
| Operating Expenses | 6.50B | 5.83B | 4.73B | 3.78B | 3.14B | 2.20B | 1.52B | 1.20B | 896.88M | 699.48M | 563.56M | 480.61M | 366.15M |
| Cost & Expenses | 20.53B | 17.86B | 13.87B | 11.93B | 9.41B | 6.37B | 4.40B | 3.45B | 2.63B | 2.04B | 1.67B | 1.45B | 1.15B |
| Interest Income | 74.34M | 73.21M | 64.15M | 58.50M | 22.13M | 9.69M | 19.52M | 15.61M | 21.27M | 6.67M | 5.13M | 4.82M | 0.00 |
| Interest Expense | 160.53M | 165.21M | 168.99M | 78.54M | 45.79M | 9.71M | 0.00 | 390.00K | 8.65M | 6.47M | 0.00 | 396.50K | 0.00 |
| Depreciation & Amortization | 1.83B | 1.59B | 1.31B | 1.04B | 190.49M | 147.87M | 110.53M | 86.90M | 27.15M | 21.69M | 20.57M | 14.59M | -105.43K |
| EBITDA | 3.85B | 3.64B | 2.70B | 2.15B | 954.81M | 661.28M | 493.16M | 402.60M | 246.63M | 206.32M | 154.48M | 108.15M | 74.59M |
| EBITDA Ratio | 17.03% | 17.74% | 17.86% | 10.59% | 9.50% | 9.85% | 10.26% | 9.44% | 8.92% | 9.53% | 8.67% | 7.11% | 6.09% |
| Operating Income | 2.05B | 1.89B | 1.34B | 1.17B | 815.47M | 578.32M | 427.19M | 296.63M | 232.86M | 184.83M | 132.79M | 91.48M | 74.70M |
| Operating Income Ratio | 9.10% | 9.48% | 8.74% | 8.90% | 7.94% | 8.37% | 8.89% | 7.94% | 8.18% | 8.29% | 7.36% | 5.94% | 6.10% |
| Total Other Income/Expenses | -17.19M | -8.05M | -961.43K | 30.43M | -1.17M | 2.86M | 908.73K | 9.69M | 6.74M | 6.49M | 2.32M | 448.39K | 3.09M |
| Income Before Tax | 2.04B | 1.88B | 1.34B | 1.16B | 814.30M | 581.26M | 428.10M | 305.84M | 239.60M | 191.32M | 135.12M | 93.17M | 77.79M |
| Income Before Tax Ratio | 9.02% | 9.44% | 8.73% | 8.85% | 7.92% | 8.41% | 8.91% | 8.19% | 8.42% | 8.58% | 7.49% | 6.05% | 6.36% |
| Income Tax Expense | 456.66M | 450.29M | 347.16M | 297.06M | 205.41M | 139.70M | 110.63M | 77.92M | 61.36M | 48.91M | 34.74M | 23.63M | 20.91M |
| Net Income | 1.41B | 1.26B | 887.88M | 743.52M | 543.75M | 416.41M | 313.50M | 223.89M | 175.94M | 140.56M | 99.19M | 68.60M | 55.88M |
| Net Income Ratio | 6.25% | 6.35% | 5.79% | 5.66% | 5.29% | 6.02% | 6.52% | 6.00% | 6.18% | 6.30% | 5.50% | 4.46% | 4.56% |
| EPS | 1.40 | 1.26 | 0.89 | 0.77 | 0.57 | 0.45 | 0.34 | 0.26 | 0.22 | 0.23 | 0.16 | 0.11 | 0.09 |
| EPS Diluted | 1.17 | 1.26 | 0.89 | 0.77 | 0.57 | 0.45 | 0.34 | 0.26 | 0.22 | 0.23 | 0.16 | 0.11 | 0.09 |
| Weighted Avg Shares Out | 1.01B | 1.01B | 994.43M | 967.36M | 959.87M | 927.43M | 924.15M | 860.44M | 780.90M | 607.03M | 608.89M | 613.08M | 605.87M |
| Weighted Avg Shares Out (Dil) | 1.21B | 1.01B | 1.00B | 967.36M | 960.80M | 927.47M | 924.55M | 860.44M | 786.46M | 607.03M | 608.99M | 613.34M | 605.87M |
Source: https://incomestatements.info
Category: Stock Reports